od Transfusions

Information about West Nile Virus and Blood Safety

Background

The ongoing outbreak of West Nile virus (WNV) infections in the United States has raised concern that WNV could be transmitted through blood transfusion. No cases of WNV attributed to transfusion of blood or blood products have been reported to date in the United States or elsewhere. Available data indicate a theoretical, albeit small, risk of WNV transmission from transfusion of blood.

FDA Blood Safety Provisions

Donor Deferral



nd 2012

CONGRESSIONAL BUDGET OFFICE

PAY-AS-YOU-GO ESTIMATE

July 8, 2002

H.R. 3448

Public Health Security and Bioterrorism Preparedness and Response Act of 2002

As cleared by the Congress on May 23, 2002, with corrections adopted in S. Con. Res. 117 on June 4, 2002, and signed by the President on June 12, 2002

SUMMARY



ys

[Federal Register: August 19, 2002 (Volume 67, Number 160)]

[Notices]

[Page 53805-53806]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr19au02-71]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 02N-0354]

Agency Emergency Processing under OMB Review; The Evaluation of Long-Term Antibiotic Drug Therapy for Persons Involved in Anthrax Remediation Activities



/index.php?option=com_iwpfile&file=/dir_01/he2002_2202.pdf


ts

NATIONAL INSTITUTES OF HEALTH

National Heart, Lung, and Blood Institute

NIH NEWS ADVISORY

FOR IMMEDIATE RELEASE

Monday, August 19, 2002

Press Contact: NHLBI Communications Office

(301) 496-4236

NIH TO HOLD WORKSHOP ON CARDIOVASCULAR EFFECTS OF SEVERAL WIDELY USED HERBAL DIETARY SUPPLEMENTS



on

Metabolife sent a similar letter to the California's Department of Health Service in May 1996. Dec 21 Letter To HHS Metabolife California Letter



56

Steven Karch, cardiac pathology and cardiac toxicology specialist, Ashraf Mozayani, chief toxicologist and laboratory director in the Harris County Medical Examiner's Office, and Craig Molgaard, professor of preventive medicine at the University of Kansas, issued reports on Metabolife 356 concluding that "there is no demonstrable connection between use of Metabolife 356 and any of the conditions reported by the Health Line callers" and "Health Line reports support a favorable safety profile of Metabolife 356."



Minnesota Attorney General Mike Hatch is planning to file litigation against drug maker Pharmacia for alleged "price fraud" on some chemotherapy drugs.



/index.php?option=com_iwpfile&file=/dir_01/he2002_2196.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2195.pdf


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.